$OPCH
Option Care Health, Inc. Stock $opch

$opch Overview Financials Valuation SEC Filings Company Website

2017 Q3 Form 10-Q Financial Statement

#000162828017008259 Filed on August 08, 2017

Income Statement

Concept	2017 Q3	2017 Q2	2016 Q2
Revenue	$198.7M	$218.1M	$232.5M
YoY Change	-11.51%	-6.18%	-5.85%
Cost Of Revenue	$132.1M	$150.5M	$168.3M
YoY Change	-18.42%	-10.58%	-7.57%
Gross Profit	$66.56M	$67.61M	$63.27M
YoY Change	7.84%	6.87%	-2.39%
Gross Profit Margin	33.5%	31.0%	27.22%
Selling, General & Admin	$15.90M	$15.80M	$13.70M
YoY Change	-10.17%	15.33%	-49.26%
% of Gross Profit	23.89%	23.37%	21.65%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$7.100M	$7.000M	$4.300M
YoY Change	69.05%	62.79%	4.12%
% of Gross Profit	10.67%	10.35%	6.8%
Operating Expenses	$62.30M	$65.10M	$58.60M
YoY Change	-3.41%	11.09%	-23.4%
Operating Profit	$4.263M	$2.511M	$4.666M
YoY Change	-253.4%	-46.19%	-101.84%
Interest Expense	-$13.40M	-$12.60M	-$9.500M
YoY Change	44.09%	32.63%	4.4%
% of Operating Profit	-314.33%	-501.79%	-203.6%
Other Income/Expense, Net
YoY Change
Pretax Income	-$13.00M	-$28.43M	-$8.770M
YoY Change	18.03%	224.2%	-96.69%
Income Tax	$60.00K	$718.0K	$149.0K
% Of Pretax Income
Net Earnings	-$12.99M	-$29.52M	-$8.750M
YoY Change	14.7%	237.41%	-96.43%
Net Earnings / Revenue	-6.54%	-13.54%	-3.76%
Basic Earnings Per Share
Diluted Earnings Per Share	-$407.5K	-$973.6K	-$448.1K
COMMON SHARES
Basic Shares Outstanding	127.5M shares	121.0M shares	68.78M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2017 Q3	2017 Q2	2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$33.00M	$40.50M	$51.40M
YoY Change	1078.57%	-21.21%	4183.33%
Cash & Equivalents	$33.01M	$40.53M	$51.43M
Short-Term Investments
Other Short-Term Assets	$20.20M	$18.10M	$16.50M
YoY Change	3.59%	9.7%	58.65%
Inventory	$27.78M	$28.82M	$32.45M
Prepaid Expenses
Receivables	$89.20M	$103.1M	$98.60M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$170.2M	$190.5M	$199.0M
YoY Change	6.78%	-4.28%	7.34%
LONG-TERM ASSETS
Property, Plant & Equipment	$28.73M	$30.06M	$30.79M
YoY Change	-14.78%	-2.36%	-11.79%
Goodwill	$367.2M	$365.9M	$308.7M
YoY Change	-1.57%	18.53%	-7.93%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.415M	$2.204M	$1.203M
YoY Change	17.52%	83.21%	0.92%
Total Long-Term Assets	$420.1M	$422.9M	$344.2M
YoY Change	-3.66%	22.85%	-12.13%
TOTAL ASSETS
Total Short-Term Assets	$170.2M	$190.5M	$199.0M
Total Long-Term Assets	$420.1M	$422.9M	$344.2M
Total Assets	$590.2M	$613.4M	$543.2M
YoY Change	-0.87%	12.91%	-5.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$42.69M	$46.38M	$48.89M
YoY Change	-6.58%	-5.13%	-36.58%
Accrued Expenses	$39.60M	$49.90M	$39.90M
YoY Change	-8.12%	25.06%	-16.18%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.800M	$1.700M	$9.400M
YoY Change	-96.27%	-81.91%	4600.0%
Total Short-Term Liabilities	$89.03M	$102.9M	$101.7M
YoY Change	-36.82%	1.2%	-24.15%
LONG-TERM LIABILITIES
Long-Term Debt	$476.8M	$475.7M	$390.1M
YoY Change	22.85%	21.94%	-6.81%
Other Long-Term Liabilities	$18.88M	$17.94M	$1.655M
YoY Change	319.35%	984.11%	-75.98%
Total Long-Term Liabilities	$18.88M	$17.94M	$1.655M
YoY Change	319.35%	984.11%	-75.98%
TOTAL LIABILITIES
Total Short-Term Liabilities	$89.03M	$102.9M	$101.7M
Total Long-Term Liabilities	$18.88M	$17.94M	$1.655M
Total Liabilities	$588.8M	$600.0M	$494.0M
YoY Change	7.05%	21.46%	-12.17%
SHAREHOLDERS EQUITY
Retained Earnings	-$704.6M	-$692.0M	-$619.7M
YoY Change	11.67%	11.68%	9.35%
Common Stock	$626.6M	$628.6M	$612.6M
YoY Change	3.28%	2.6%	14.7%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$16.00K		$11.01M
YoY Change			2.74%
Treasury Stock Shares	5.106K shares		2.761M shares
Shareholders Equity	-$78.00M	-$63.49M	-$18.08M
YoY Change
Total Liabilities & Shareholders Equity	$590.2M	$613.4M	$543.2M
YoY Change	-0.87%	12.91%	-5.87%

Cashflow Statement

Concept	2017 Q3	2017 Q2	2016 Q2
OPERATING ACTIVITIES
Net Income	-$12.99M	-$29.52M	-$8.750M
YoY Change	14.7%	237.41%	-96.43%
Depreciation, Depletion And Amortization	$7.100M	$7.000M	$4.300M
YoY Change	69.05%	62.79%	4.12%
Cash From Operating Activities	-$4.400M	$6.000M	-$10.60M
YoY Change	-73.96%	-156.6%	-41.76%
INVESTING ACTIVITIES
Capital Expenditures	-$2.300M	-$2.600M	-$3.100M
YoY Change	-8.0%	-16.13%	-16.22%
Acquisitions
YoY Change
Other Investing Activities			$0.00
YoY Change
Cash From Investing Activities	-$2.300M	-$2.600M	-$3.000M
YoY Change	-96.57%	-13.33%	-18.92%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-900.0K	21.10M	57.00M
YoY Change	-102.54%	-62.98%	-28600.0%
NET CHANGE
Cash From Operating Activities	-4.400M	6.000M	-10.60M
Cash From Investing Activities	-2.300M	-2.600M	-3.000M
Cash From Financing Activities	-900.0K	21.10M	57.00M
Net Change In Cash	-7.600M	24.50M	43.40M
YoY Change	-84.36%	-43.55%	-296.38%
FREE CASH FLOW
Cash From Operating Activities	-$4.400M	$6.000M	-$10.60M
Capital Expenditures	-$2.300M	-$2.600M	-$3.100M
Free Cash Flow	-$2.100M	$8.600M	-$7.500M
YoY Change	-85.42%	-214.67%	-48.28%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016Q4	bios	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	42191000	USD
CY2017Q2	bios	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	43209000	USD
CY2016Q2	bios	Acquisition Integration Restructuringand Other Expenses AcquisitionIntegrationRestructuringandOtherExpenses	4291000	USD
	bios	Acquisition Integration Restructuringand Other Expenses AcquisitionIntegrationRestructuringandOtherExpenses	6958000	USD
CY2017Q2	bios	Acquisition Integration Restructuringand Other Expenses AcquisitionIntegrationRestructuringandOtherExpenses	3911000	USD
	bios	Acquisition Integration Restructuringand Other Expenses AcquisitionIntegrationRestructuringandOtherExpenses	7134000	USD
CY2016Q4	bios	Amounts Due To Plan Sponsors AmountsDueToPlanSponsors	3799000	USD
CY2017Q2	bios	Amounts Due To Plan Sponsors AmountsDueToPlanSponsors	4825000	USD
CY2017Q2	bios	Debt And Warrants Outstanding DebtAndWarrantsOutstanding	494847000	USD
CY2016Q2	bios	Gain Losson Changein Fair Valueof Contingent Consideration GainLossonChangeinFairValueofContingentConsideration	-51000	USD
	bios	Gain Losson Changein Fair Valueof Contingent Consideration GainLossonChangeinFairValueofContingentConsideration	-102000	USD
CY2017Q2	bios	Gain Losson Changein Fair Valueof Contingent Consideration GainLossonChangeinFairValueofContingentConsideration	0	USD
	bios	Gain Losson Changein Fair Valueof Contingent Consideration GainLossonChangeinFairValueofContingentConsideration	0	USD
	bios	Gain Losson Dispositionof Property Plant Equipment1 GainLossonDispositionofPropertyPlantEquipment1	939000	USD
	bios	Gain Losson Dispositionof Property Plant Equipment1 GainLossonDispositionofPropertyPlantEquipment1	-685000	USD
	bios	Increase Decreasein Amounts Due To Plan Sponsor IncreaseDecreaseinAmountsDueToPlanSponsor	62000	USD
	bios	Increase Decreasein Amounts Due To Plan Sponsor IncreaseDecreaseinAmountsDueToPlanSponsor	1027000	USD
	bios	Increase Decreasein Fair Valueof Contingent Consideration IncreaseDecreaseinFairValueofContingentConsideration	-102000	USD
	bios	Increase Decreasein Fair Valueof Contingent Consideration IncreaseDecreaseinFairValueofContingentConsideration	0	USD
CY2015Q3	bios	Proceedsfrom Issuanceof Equityand Temporary Equity ProceedsfromIssuanceofEquityandTemporaryEquity	1100000	USD
CY2016Q2	bios	Saleof Stock Equity Issuable Amount SaleofStockEquityIssuableAmount	200000000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
	dei	Document Period End Date DocumentPeriodEndDate	2017-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001014739
CY2017Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	127475226	shares
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	BioScrip, Inc.
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	59134000	USD
CY2017Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	46381000	USD
CY2016Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	156541000	USD
CY2017Q2	us-gaap	Accounts Receivable Gross AccountsReceivableGross	148740000	USD
CY2016Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	111811000	USD
CY2017Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	103089000	USD
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	611844000	USD
CY2017Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	628545000	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	44730000	USD
CY2017Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	45651000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2875000	USD
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	25000	USD
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	25000	USD
	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	280000	USD
CY2017Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	45651000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1987000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	939000	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	44730000	USD
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	0	USD
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	1327000	USD
CY2017Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	127441893	shares
CY2016Q4	us-gaap	Assets Assets	607740000	USD
CY2017Q2	us-gaap	Assets Assets	613383000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	176052000	USD
CY2017Q2	us-gaap	Assets Current AssetsCurrent	190497000	USD
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	117682543	shares
CY2017Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	127441893	shares
CY2016Q2	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	2924000	USD
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	12000	USD
CY2017Q2	us-gaap	Common Stock Value CommonStockValue	13000	USD
	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	2924000	USD
CY2017Q2	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	263000	USD
CY2016Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4252000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	8790000	USD
CY2017Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6789000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	13777000	USD
CY2016Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	14000000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	15500000	shares
CY2017Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	18300000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	18400000	shares
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15577000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	51425000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9569000	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	40533000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	35848000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	30964000	USD
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-5913000	USD
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-940000	USD
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2017Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2017Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	117682543	shares
CY2016Q2	us-gaap	Cost Of Revenue CostOfRevenue	168298000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	342528000	USD
CY2017Q2	us-gaap	Cost Of Revenue CostOfRevenue	149796000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	302022000	USD
CY2016Q2	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2017Q2	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2016Q2	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	25000	USD
CY2017Q2	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	190000	USD
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	226000	USD
CY2016Q2	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	25000	USD
CY2017Q2	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	190000	USD
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	226000	USD
	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	22000	USD
CY2017Q2	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	91000	USD
CY2017Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-685000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-685000	USD
CY2016Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2017Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-13453000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-13453000	USD
	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	179000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Gross Noncurrent DeferredTaxLiabilitiesGrossNoncurrent	2281000	USD
CY2016Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9414000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	20465000	USD
CY2017Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10025000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	19504000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	365947000	USD
CY2017Q2	us-gaap	Goodwill Goodwill	365947000	USD
CY2016Q2	us-gaap	Gross Profit GrossProfit	64164000	USD
	us-gaap	Gross Profit GrossProfit	128396000	USD
CY2016Q2	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	108000	USD
	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	125000	USD
CY2017Q2	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	437000	USD
	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	932000	USD
CY2016Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	12452000	USD
CY2017Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	3668000	USD
CY2016Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	124000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	147000	USD
CY2017Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	528000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1111000	USD
CY2016Q2	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	16000	USD
CY2017Q2	us-gaap	Deferred Tax Liabilities Gross Noncurrent DeferredTaxLiabilitiesGrossNoncurrent	3504000	USD
	us-gaap	Depreciation Depreciation	8790000	USD
	us-gaap	Depreciation Depreciation	13777000	USD
CY2016Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.14
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.32
CY2017Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.26
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.45
CY2016Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	31043000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	24672000	USD
CY2016Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2017Q2	us-gaap	Gross Profit GrossProfit	68310000	USD
	us-gaap	Gross Profit GrossProfit	133894000	USD
CY2016Q2	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	232462000	USD
	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	470924000	USD
CY2017Q2	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	218106000	USD
	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	435916000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-8309000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-18079000	USD
CY2017Q2	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.26
	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.44
CY2017Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-28695000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-47686000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-8160000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-17907000	USD
CY2017Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-27977000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-46349000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.14
	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.32
CY2016Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	75000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	308000	USD
CY2017Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-503000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-940000	USD
CY2016Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	0.00
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	0.00
CY2017Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	0.00
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	-0.01
CY2016Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	149000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	172000	USD
CY2017Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	718000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1337000	USD
CY2016Q2	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1926000	USD
	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	5314000	USD
CY2017Q2	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	10266000	USD
	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	17242000	USD
CY2016Q2	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-2844000	USD
	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-6271000	USD
CY2017Q2	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-9790000	USD
	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-16236000	USD
CY2016Q2	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	1064000	USD
	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	1126000	USD
CY2017Q2	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	52000	USD
	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	105000	USD
CY2016Q2	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	3000	USD
	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	3000	USD
CY2017Q2	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	190000	USD
	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	226000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	229000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	249000	USD
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-16190000	USD
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-12753000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-352000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-1223000	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-192000	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	31000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-10537000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-155000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1132000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2017Q2	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	477405000	USD
	us-gaap	Interest Paid Net InterestPaidNet	17325000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	61771000	USD
CY2017Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-12715000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-25459000	USD
CY2016Q4	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	451934000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-7343000	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-3140000	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	714000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-322000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-5469000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	1281000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-8721000	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	5055000	USD
CY2016Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-9469000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-18881000	USD
	us-gaap	Interest Paid Net InterestPaidNet	22613000	USD
CY2016Q4	us-gaap	Interest Payable Current InterestPayableCurrent	6705000	USD
CY2017Q2	us-gaap	Interest Payable Current InterestPayableCurrent	6736000	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	36165000	USD
CY2017Q2	us-gaap	Inventory Net InventoryNet	28822000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	567301000	USD
CY2017Q2	us-gaap	Liabilities Liabilities	600002000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	607740000	USD
CY2017Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	613383000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	130350000	USD
CY2017Q2	us-gaap	Liabilities Current LiabilitiesCurrent	102882000	USD
CY2016Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	433413000	USD
CY2017Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	475674000	USD
CY2016Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	18521000	USD
CY2017Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	1731000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	45345000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4334000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-9347000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-21589000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5034000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-15676000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-4094000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	-8234000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-17771000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	-29198000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-48626000	USD
CY2016Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10463000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-22170000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4292000	USD
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2017Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	45000000	USD
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	563000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-93000	USD
CY2017Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-31676000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-53492000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2163000	USD
CY2017Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2204000	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1257000	USD
CY2017Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	17942000	USD
CY2016Q2	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	40619000	USD
	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	80277000	USD
CY2017Q2	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	42486000	USD
	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	86844000	USD
	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	USD
	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	311000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5466000	USD
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2017Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	18507000	USD
CY2017Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	12998000	USD
	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	0	USD
	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	23060000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	83267000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	20776000	USD
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0	USD
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	294446000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	32535000	USD
CY2017Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	30063000	USD
CY2016Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	4279000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	11871000	USD
CY2017Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	6223000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	13387000	USD
CY2016Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	111811000	USD
CY2017Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	103089000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1993000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1027000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	129000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	401000	USD
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	60000000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	-31563000	USD
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	55863000	USD
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	6274000	USD
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	236770000	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	0	USD
CY2017Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	5055000	USD
CY2016Q2	us-gaap	Restructuring Charges RestructuringCharges	1316000	USD
	us-gaap	Restructuring Charges RestructuringCharges	3932000	USD
CY2017Q2	us-gaap	Restructuring Charges RestructuringCharges	3648000	USD
	us-gaap	Restructuring Charges RestructuringCharges	6854000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-643419000	USD
CY2017Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-692045000	USD
CY2017Q2	us-gaap	Stockholders Equity StockholdersEquity	-63487000	USD
CY2016Q2	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	173000	USD
	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	345000	USD
CY2017Q2	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	175000	USD
	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	349000	USD
CY2016Q2	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	2056000	USD
	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	4054000	USD
CY2017Q2	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	2303000	USD
	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	4517000	USD
CY2016Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	73186000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	70978000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	121189000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	119993000	shares

Files In Submission

Name	View Source	Status
0001628280-17-008259-index-headers.html	Edgar Link	pending
0001628280-17-008259-index.html	Edgar Link	pending
0001628280-17-008259.txt	Edgar Link	pending
0001628280-17-008259-xbrl.zip	Edgar Link	pending
bios-20170630.xml	Edgar Link	completed
bios-20170630.xsd	Edgar Link	pending
bios-20170630x10q.htm	Edgar Link	pending
bios-20170630_cal.xml	Edgar Link	unprocessable
bios-20170630_def.xml	Edgar Link	unprocessable
bios-20170630_lab.xml	Edgar Link	unprocessable
bios-20170630_pre.xml	Edgar Link	unprocessable
bios-ex311x20170630x10q.htm	Edgar Link	pending
bios-ex312x20170630x10q.htm	Edgar Link	pending
bios-ex321x20170630x10q.htm	Edgar Link	pending
bios-ex322x20170630x10q.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
logowithregisteredtm06.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OPCH
Option Care Health, Inc. Stock $opch

2017 Q3 Form 10-Q Financial Statement

#000162828017008259 Filed on August 08, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPCH Option Care Health, Inc. Stock $opch

2017 Q3 Form 10-Q Financial Statement

#000162828017008259 Filed on August 08, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPCH
Option Care Health, Inc. Stock $opch